Humanized Mouse as a Tool to Predict Immunotoxicity of Human Biologics.

Frontiers in Immunology
Kylie Su Mei YongQingfeng Chen

Abstract

Advancements in science enable researchers to constantly innovate and create novel biologics. However, the use of non-human animal models during the development of biologics impedes identification of precise in vivo interactions between the human immune system and treatments. Due to lack of this understanding, adverse effects are frequently observed in healthy volunteers and patients exposed to potential biologics during clinical trials. In this study, we evaluated and compared the effects of known immunotoxic biologics, Proleukin®/IL-2 and OKT3 in humanized mice (reconstituted with human fetal cells) to published clinical outcomes. We demonstrated that humanized mice were able to recapitulate in vivo pathological changes and human-specific immune responses, such as elevated cytokine levels and modulated lymphocytes and myeloid subsets. Given the high similarities of immunological side effects observed between humanized mice and clinical studies, this model could be used to assess immunotoxicity of biologics at a pre-clinical stage, without placing research participants and/or patients at risk.

References

Jan 1, 1991·Kidney International·R S GastonJ J Curtis
Nov 1, 1982·European Journal of Immunology·L ChatenoudJ F Bach
Jul 1, 1995·American Journal of Respiratory and Critical Care Medicine·Y BerthiaumeR Lafrenière
Jan 1, 1993·International Reviews of Immunology·L K Jolliffe
Aug 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G A FyfeA C Louie
Apr 16, 1998·The Journal of Clinical Investigation·V Taneja, C S David
May 14, 1999·European Journal of Drug Metabolism and Pharmacokinetics·P M DansetteD Mansuy
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B AtkinsS A Rosenberg
Nov 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·P A CarpenterC Anasetti
Sep 11, 2002·Psychotherapy and Psychosomatics·Michael W Otto, Andrew A Nierenberg
Feb 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Javier Mestas, Christopher C W Hughes
Dec 24, 2004·The New England Journal of Medicine·Philip F Halloran
Feb 5, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jacques Descotes
Dec 22, 2005·Nature Immunology·Peter M Henson
Aug 16, 2006·The New England Journal of Medicine·Ganesh SuntharalingamNicki Panoskaltsis
Dec 13, 2006·European Journal of Immunology·Jun WangRené E M Toes
Dec 22, 2006·European Journal of Immunology·Steven F Ziegler
Jun 7, 2007·Immunology and Cell Biology·Ian A Clark
Jan 19, 2008·Clinical Pharmacology and Therapeutics·I Kola
Apr 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Koen VenkenPiet Stinissen
May 21, 2008·Current Protocols in Immunology·Todd PearsonLeonard D Shultz
Apr 23, 2009·Cancer Research·Ilona KryczekWeiping Zou
May 20, 2009·Journal of Immunological Methods·Magis MandapathilTheresa L Whiteside
Nov 18, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jean M FletcherKingston H G Mills
Dec 8, 2009·Proceedings of the National Academy of Sciences of the United States of America·Qingfeng ChenJianzhu Chen
Feb 13, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity·Michael A BrehmDale L Greiner
Jun 16, 2010·Proceedings of the National Academy of Sciences of the United States of America·Carsten KriegOnur Boyman
Aug 18, 2010·Current Medicinal Chemistry·G K Antony, A Z Dudek
Nov 3, 2010·Journal of Young Pharmacists : JYP·H Attarwala
Nov 26, 2010·Cancer Research·Natalia Martin-OrozcoLaszlo Radvanyi
Jan 27, 2011·Nature Reviews. Immunology·Daniel J Campbell, Meghan A Koch
Feb 3, 2011·Methods in Molecular Biology·Shimon Sakaguchi
May 3, 2011·Nature Reviews. Drug Discovery·John Arrowsmith

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
FACS
ELISA

Software Mentioned

Flowjo
[UNK] Data Analysis
GraphPad
FACSDiva
GraphPad Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Chitra DinakarStephen A Tilles
Zeitschrift für Rheumatologie
J R Kalden
Journal of the American Academy of Dermatology
Warren R Heymann
© 2021 Meta ULC. All rights reserved